MoonLake Immunotherapeutics

NASDAQ:MLTX

38.55 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020
Operating Activities:
Net Income -121,244.4-44.079-64.506-53.644-0.091
Depreciation & Amortization 1,384.7290.0130.0120.0050
Deferred Income Tax 0001.40
Stock Based Compensation 7,281.5967.1060.010.0110
Change In Working Capital 0-6.218-1.4274.484-0.216
Accounts Receivables 00-0.068-0.1490
Inventory 00000
Accounts Payables 00-1.3141.5690
Other Working Capital -1.997-6.218-0.0453.064-0.216
Other Non Cash Items -4,009.1880.40.37212.569-0.01
Operating Cash Flow -116,587.263-42.778-55.894-35.175-0.317
Investing Activities:
Investments In Property Plant And Equipment -519.52-0.285-0.016-0.0510
Acquisitions Net 000.03200
Purchases Of Investments -350,278.776-175.733-42.2260-115
Sales Maturities Of Investments 145,202.997150.8339.90100
Other Investing Activites 00-0.03200
Investing Cash Flow -205,595.299-25.184-32.341-0.051-115
Financing Activities:
Debt Repayment 00-15150
Common Stock Issued 52.54482.4540.00428.269117
Common Stock Repurchased 000-0.0060
Dividends Paid 00000
Other Financing Activities 51,259.168-2.753134.6930-0.347
Financing Cash Flow 51,311.708479.702119.69343.263116.653
Other Information:
Effect Of Forex Changes On Cash 127.966-0.0750.00900
Net Change In Cash -270,742.888411.66431.4676.7031.336
Cash At End Of Period 180,426.449451.16939.5068.0391.336